Montelukast ODF (NAL Pharma)

N/A

Report date: 2025/03/26 11:40:42

Base Information

Drug NameMontelukast ODF (NAL Pharma)
Drug Alias NameMontelukast orally-dissolving filmNAL6336NAL-6336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCysteinyl leukotriene receptor 1 antagonists
TargetsCysteinyl leukotriene receptor 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNal Pharma LTD
China Registration ClassN/A

Develop Information

Active CompaniesNal Pharma LTD
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A